Profile
Gryphon Investors is a private equity firm based in San Francisco, established in 1995 by David Andrews. It operates with a team of over 60 investment professionals and 15 dedicated operating partners. The firm emphasizes a collaborative and inclusive approach, integrating investment expertise with operational leadership to foster growth in its portfolio companies. This differentiated approach serves the needs of middle-market management teams effectively.
Gryphon specializes in investing in lower-middle-market companies across various sectors including business services, consumer products, healthcare, industrial growth, and technology solutions. The firm typically engages in control equity investments, focusing on stages from Series A to late-stage financing. With over $10 billion in assets under management, Gryphon's investment strategies include the Flagship, Heritage, and Junior Capital funds. The firm is supported by a diverse group of limited partners, including US and international pension plans and family offices.
Notable portfolio companies under Gryphon Investors' management include Aqua Dermatology – healthcare services, Kano Laboratories – consumer products, Milani – cosmetics, and Vessco Water – water management solutions. Gryphon's commitment to building market leaders with enduring competitive advantages has been highlighted through numerous platform investments and add-on acquisitions.
Industry
Gryphon Investors Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Gryphon VI Top-Up Co-Investment Partners
|
Private Equity (PE)
|
Business Services (B2B)
Consumer Products
Healthcare Services
Industrial
Technology
|
Series A
Series B
Late Stage (Series C+)
|
North America
|
$50-100 m
|
$770 M
|
August 2026
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.